- Home
- RLYB vs UCL Comparison
RLYB vs UCL Comparison
Compare RLYB & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLYB
- UCL
- Stock Information
- Founded
- RLYB 2018
- UCL 2014
- Country
- RLYB United States
- UCL Hong Kong
- Employees
- RLYB N/A
- UCL N/A
- Industry
- RLYB Biotechnology: Pharmaceutical Preparations
- UCL Telecommunications Equipment
- Sector
- RLYB Health Care
- UCL Consumer Discretionary
- Exchange
- RLYB Nasdaq
- UCL Nasdaq
- Market Cap
- RLYB 14.4M
- UCL 70.6M
- IPO Year
- RLYB 2021
- UCL 2020
- Fundamental
- Price
- RLYB $0.41
- UCL $1.92
- Analyst Decision
- RLYB Hold
- UCL
- Analyst Count
- RLYB 3
- UCL 0
- Target Price
- RLYB $15.00
- UCL N/A
- AVG Volume (30 Days)
- RLYB 8.1M
- UCL 51.0K
- Earning Date
- RLYB 08-07-2025
- UCL 08-13-2025
- Dividend Yield
- RLYB N/A
- UCL N/A
- EPS Growth
- RLYB N/A
- UCL N/A
- EPS
- RLYB N/A
- UCL 0.09
- Revenue
- RLYB $848,000.00
- UCL $92,256,000.00
- Revenue This Year
- RLYB N/A
- UCL $6.09
- Revenue Next Year
- RLYB N/A
- UCL $7.01
- P/E Ratio
- RLYB N/A
- UCL $20.26
- Revenue Growth
- RLYB N/A
- UCL 7.65
- 52 Week Low
- RLYB $0.22
- UCL $0.80
- 52 Week High
- RLYB $1.54
- UCL $3.30
- Technical
- Relative Strength Index (RSI)
- RLYB 55.26
- UCL 58.25
- Support Level
- RLYB $0.32
- UCL $1.79
- Resistance Level
- RLYB $0.61
- UCL $1.96
- Average True Range (ATR)
- RLYB 0.05
- UCL 0.14
- MACD
- RLYB 0.01
- UCL -0.02
- Stochastic Oscillator
- RLYB 34.82
- UCL 33.97
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.